Evidence map›Paper›PMID 32471362›Full record

ArticleThe journal of headache and pain2020

The impact of remission and coexisting migraine on anxiety and depression in cluster headache.

Byung-Su Kim, Pil-Wook Chung, Byung-Kun Kim, Mi Ji Lee, Jeong Wook Park, Min Kyung Chu, Jin-Young Ahn, Dae Woong Bae, Tae-Jin Song, Jong-Hee Sohn and 10 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in The journal of headache and pain, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Observational
  5. Observational
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 2 countries.

Byung-Su KimDepartment of Neurology, Bundang Jesaeng General Hospital, Daejin Medical Center, Seongnam, South Korea.
Pil-Wook ChungDepartment of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Byung-Kun KimDepartment of Neurology, Eulji Hospital, Eulji University, Seoul, South Korea.
Mi Ji LeeDepartment of Neurology, Neuroscience Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Jeong Wook ParkDepartment of Neurology, Uijeongbu St.Mary's Hospital, The Catholic University of Korea College of Medicine, Uijeongbu, South Korea.
Min Kyung ChuDepartment of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
Jin-Young AhnDepartment of Neurology, Seoul Medical Center, Seoul, South Korea.
Dae Woong BaeDepartment of Neurology, College of Medicine, The Catholic University of Korea, Suwon, South Korea.
Tae-Jin SongDepartment of Neurology, Ewha Womans University Seoul Hospital, College of Medicine, Seoul, South Korea.
Jong-Hee SohnDepartment of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, South Korea.
Kyungmi OhDepartment of Neurology, Korea University College of Medicine, Seoul, South Korea.
Daeyoung KimDepartment of Neurology, Chungnam National University College of Medicine, Daejeon, South Korea.
Jae-Moon KimDepartment of Neurology, Chungnam National University College of Medicine, Daejeon, South Korea.
Soo-Kyoung KimDepartment of Neurology, Gyeongsang National University College of Medicine, Jinju, South Korea.
Yun-Ju ChoiDr. Choi's Neurology Clinic, Jeonju, South Korea.
Jae Myun ChungDepartment of Neurology, Inje University College of Medicine, Seoul, South Korea.
Heui-Soo MoonDepartment of Neurology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Chin-Sang ChungDepartment of Neurology, Neuroscience Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kwang-Yeol ParkDepartment of Neurology, Chung-Ang University Hospital, 102 Heukseok-ro, Dongjak-gu, Seoul, 06973, South Korea. kwangyeol.park@gmail.com.
Soo-Jin ChoDepartment of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Keun Jae Bong-gil 7, Hwaseong, Gyeonggi-do, 18450, South Korea. dowonc@naver.com.ORCID http://orcid.org/0000-0002-4053-3763
Chungnam National University · KREulji University · KRKangbuk Samsung Hospital · KRSamsung Medical Center · KRChung-Ang University Hospital · KREwha Womans University · KRGyeongsang National University · KRHallym University · KRInje University · KRKorea University · KRSacred Heart Hospital · NGSeoul Medical Center · KRSuwon Catholic University · KRThe Catholic University of Korea Uijeongbu St. Mary's Hospital · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur aim was to investigate the relationship between coexisting cluster headache (CH) and migraine with anxiety and depression during active cluster bouts, and how symptoms change during remission.

methodsWe analyzed data from 222 consecutive CH patients and 99 age- and sex-matched controls using a prospective multicenter registry. Anxiety or depression was evaluated using the Generalized Anxiety Disorder-7 (GAD-7) or Patient Health Questionnaire-9 (PHQ-9), respectively. Moderate-to-severe anxiety or depression was defined as a score of ≥10 at baseline (during a cluster bout). We assessed for changes in anxiety and depression during CH remission periods.

resultsAmong the CH patients, the prevalence of moderate-to-severe anxiety and depression was seen in 38.2% and 34.6%, respectively. Compared with controls, CH patients were associated with moderate-to-severe anxiety and depression (multivariable-adjusted odds ratio [aOR] = 7.32, 95% confidence intervals [CI] = 3.35-15.99 and aOR = 4.95, 95% CI = 2.32-10.57, respectively). CH patients with migraine were significantly more likely to have moderate-to-severe anxiety and depression (aOR = 32.53, 95% CI = 6.63-159.64 and aOR = 16.88, 95% CI = 4.16-68.38, respectively), compared to controls without migraine. The GAD-7 and PHQ-9 scores were significantly reduced between cluster bout and remission periods (from 6.8 ± 5.6 to 1.6 ± 2.8; P < 0.001, and from 6.1 ± 5.0 to 1.8 ± 2.4; P < 0.001, respectively).

conclusionsOur results indicate that CH patients are at increased risk of anxiety and depression, especially in the presence of coexisting migraine. However, the anxiety and depression can improve during remission periods.

Indexed as

AdolescentAdultAnxietyCluster HeadacheComorbidityCross-Sectional StudiesDepressionFemaleFollow-Up StudiesHumansMaleMiddle AgedMigraine DisordersPrevalenceProspective StudiesRemission InductionAnxietyCluster headacheDepressionHeadacheMigraine

Identifiers

PMID32471362
PMCPMC7257141
OpenAlexW3030747575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.